1. A167 CATEGORIZING ENDOSCOPIC SEVERITY OF CROHN'S DISEASE USING THE MODIFIED MULTIPLIER SES-CD (MM-SES-CD). (21st February 2022) Authors: Pray, C; Narula, N; Wong, E C; Colombel, J; Marshall, J; Daperno, M; Reinisch, W; Dulai, P S Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 5(2022)Supplement 1 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A176 ASSOCIATIONS OF ANTIBIOTICS, HORMONAL THERAPIES, ORAL CONTRACEPTIVES, AND LONG-TERM NSAIDS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY. (7th March 2023) Authors: Pray, C; Narula, N; Wong, E C; Marshall, J K; Rangarajan, S; Islam, S; Bahonar, A; Alhabib, K F; Kontsevaya, A; Ariffin, F; Co, H U; Al Sharief, W; Szuba, A; Wielgosz, A; Diaz, M L; Yusuf, R; Kruger, L; Soman, B; Li, Y; Wang, C Journal: Journal of the Canadian Association of Gastroenterology Issue: Volume 6(2023)Supplement 1 Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P247 Comparison of discontinuation/switching between infliximab biosimilar and originator among Inflammatory Bowel Disease patients: a real-world analysis of two Canadian cohorts. (21st January 2022) Authors: Moura, C S; Lukusa, L; Wong, E C; Lakatos, P L; Afif, W; Narula, N; Bernatsky, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗